Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

[1]  T. Kündig,et al.  Active vaccination against interleukin‐5 as long‐term treatment for insect‐bite hypersensitivity in horses , 2018, Allergy.

[2]  T. Kündig,et al.  Treating insect‐bite hypersensitivity in horses with active vaccination against IL‐5 , 2018, The Journal of allergy and clinical immunology.

[3]  M. Bachmann,et al.  Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. , 2018, The Journal of allergy and clinical immunology.

[4]  O. Pfaar,et al.  Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy , 2018, Allergy.

[5]  T. Kündig,et al.  Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling , 2018, The Journal of Immunology.

[6]  Jin Zhao,et al.  The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide , 2018, Theranostics.

[7]  C. Bowen,et al.  Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control , 2018, Journal of Biomedical Science.

[8]  Catherine J. Wu,et al.  Towards personalized, tumour-specific, therapeutic vaccines for cancer , 2017, Nature Reviews Immunology.

[9]  A. Mellor,et al.  Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now? , 2017, Front. Immunol..

[10]  D. Stuart,et al.  Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy , 2017, npj Vaccines.

[11]  Jamal S. Lewis,et al.  Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach. , 2017, Bioconjugate chemistry.

[12]  Taekwang Keum,et al.  Vaccine adjuvants: smart components to boost the immune system , 2017, Archives of pharmacal research.

[13]  T. D. de Gruijl,et al.  Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials , 2017, Clinical Cancer Research.

[14]  M. Bachmann,et al.  Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria , 2017, Vaccines.

[15]  M. Bachmann,et al.  Major findings and recent advances in virus-like particle (VLP)-based vaccines. , 2017, Seminars in immunology.

[16]  D. O'hagan,et al.  Towards an evidence based approach for the development of adjuvanted vaccines. , 2017, Current opinion in immunology.

[17]  M. Bachmann,et al.  Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax , 2017, Vaccines.

[18]  M. Bachmann,et al.  Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[19]  N. Silman,et al.  Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza , 2017, BMC Infectious Diseases.

[20]  L. Klimek,et al.  Clinical use of adjuvants in allergen-immunotherapy , 2017, Expert review of clinical immunology.

[21]  W. Overwijk,et al.  Adjuvants for peptide-based cancer vaccines , 2016, Journal of Immunotherapy for Cancer.

[22]  D. Speiser,et al.  Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope , 2016, Oncoimmunology.

[23]  G. Jennings,et al.  Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes. , 2016, Molecular Therapy.

[24]  K. Ishii,et al.  Vaccine adjuvants as potential cancer immunotherapeutics , 2016, International immunology.

[25]  M. Mihm,et al.  Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy. , 2016, Pathology.

[26]  D. Leclerc,et al.  Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants , 2015, Vaccines.

[27]  M. Mihm,et al.  Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response , 2015, Cancer Immunology Research.

[28]  Z. Naraghi,et al.  Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma , 2015, Indian journal of dermatology.

[29]  D. Schrijvers,et al.  Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs. , 2015, Pharmacology & therapeutics.

[30]  Dimitri Perrin,et al.  Whole-Body Imaging with Single-Cell Resolution by Tissue Decolorization , 2014, Cell.

[31]  I. Müller,et al.  Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages , 2014, Front. Immunol..

[32]  C. Liu,et al.  Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion , 2013, Nature Medicine.

[33]  R. Dummer,et al.  Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients , 2012, European journal of immunology.

[34]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[35]  Jennifer A. Prescher,et al.  Copper-free click chemistry in living animals , 2010, Proceedings of the National Academy of Sciences.

[36]  H. Volk,et al.  Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study , 2008, The Lancet.

[37]  Carolyn R. Bertozzi,et al.  Copper-free click chemistry for dynamic in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[38]  M. Nuzzaci,et al.  Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope , 2007, Archives of Virology.

[39]  H. Volk,et al.  A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity , 2007, Journal of hypertension.

[40]  A. Krieg,et al.  Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.

[41]  D. Speiser,et al.  Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. , 2005, The Journal of clinical investigation.

[42]  D. Boscia,et al.  Immunogenic Properties of a Chimeric Plant Virus Expressing a Hepatitis C Virus (HCV)-Derived Epitope: New Prospects for an HCV Vaccine , 2005, Journal of Clinical Immunology.

[43]  K. Schwarz,et al.  Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.

[44]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[45]  A. Wheeler,et al.  A Th1-Inducing Adjuvant, MPL®, Enhances Antibody Profiles in Experimental Animals Suggesting It Has the Potential to Improve the Efficacy of Allergy Vaccines , 2001, International Archives of Allergy and Immunology.

[46]  L. Hültner,et al.  Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. , 1999, Journal of immunology.

[47]  K. Heeg,et al.  Bacterial DNA causes septic shock , 1997, Nature.

[48]  J. Cox,et al.  Adjuvants--a classification and review of their modes of action. , 1997, Vaccine.

[49]  H. Stills.  Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. , 2005, ILAR journal.

[50]  Harold F. Stils.  Adjuvants and Antibody Production: Dispelling the Myths Associated with Freund's Complete and Other Adjuvants , 2005 .

[51]  A. Wheeler,et al.  l-Tyrosine as an immunological adjuvant. , 1982, International archives of allergy and applied immunology.